Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Vium combined computer vision, machine learning, and sensor technology to build “digital vivariums” that collected noninvasive data on the health of animals used in preclinical research. Recursion acquired the company in 2020.
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules